Google
ICCM — ICECURE MEDICAL (Healthcare >> Medical Devices)
ICCM FAQ
What is ICCM's ROE?
ICECURE MEDICAL reports a Return on Equity (ROE) of -185.34%.
What is ICCM's dividend yield?
ICECURE MEDICAL offers a dividend yield of 0.00%.
What is ICCM's Deepscope Quality Score?
Deepscope rates ICCM's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ICCM?
Deepscope's AI Timing Score for ICCM is 96 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ICCM belong to?
ICECURE MEDICAL is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 5.22
Price
5.07
(3,341.00%)
Day Change
|
|
|---|
ICCM, the overall quality is not good ( Quality = 31) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...
| Quality Factors |
|
47% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 78 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 5.22 |
| PBV / Sector |
1.33 / 7.50
GOOD
|
| Earning Per Share | -7.28 |
| PE / Sector |
N/A / 28.68
|
| PEG or PE/Growth / Sector |
N/A / 0.39
|
| Average 1M Daily Value |
0.36 M
GREAT
|
| Average 1W Daily Value |
0.97 M
GREAT
|
| Timing Factors |
|
100% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
52% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-05 09:12:26 |
| Symbol | ICCM |
| Name | ICECURE MEDICAL |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 81.24 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 11.29 / 18,060.39 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 7 Ha?Eshel St., Caesarea, Israel, 3079504
Phone: 972 4 623 0333
Website: https://www.icecure-medical.com
Employees: 67
Sector: Healthcare >> Medical Devices
Description: IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics. IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
